“Advances in the Pharmacotherapy of Heart Failure: Type 2 Sodium-Glucose Cotransporter Inhibitors (SGLT2) As a Therapeutic Option”. Research, Society and Development, vol. 12, no. 3, Mar. 2023, p. e12412340502, https://doi.org/10.33448/rsd-v12i3.40502.